Upgrade to SI Premium - Free Trial

Edwards Lifesciences (EW) PT Lowered to $118 at Barclays on 3Q; 'Quarter Over Quarter Slowdown in U.S. TAVR Growth'

October 25, 2017 12:36 PM
Barclays lowered its price target on Edwards Lifesciences (NYSE: EW) to $118.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles